{"podcast":{"title":"Montpelier News Today | 2 Min New | The Daily News Now!","slug":"montpelier-news-today-2-min-new-the-daily-news-now-7598987","podcast_index_feed_id":7598987,"rss_url":"https://feeds.fastcast.ai/montpelier-daily-news-now.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/podcasts/montpelier-daily-news-now.jpg","author":"The Daily News Now!","episode_count":562,"summary":"Hosted by Corey with the Story, Montpelier News Today delivers daily coverage of everything happening in Montpelier with fast, focused updates on local news, government, business, public safety, and the stories shaping Vermont’s capital. From breaking developments to community updates, the show keeps you informed on what matters most. Each short episode highlights what matters most—including key updates, local trends, and essential headlines—produced by AI for speed, consistency, and clarity. Part of The Daily News Now network, Montpelier News Today is built for listeners who want reliable local news every single day. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-07-18T06:19:54.726763+00:00","page_url":"https://stenobird.com/podcast/montpelier-news-today-2-min-new-the-daily-news-now-7598987"},"episode":{"title":"GLP-1 Drugs in Question | Montpelier News","slug":"glp-1-drugs-in-question-montpelier-news","published_at":"2026-07-18T04:28:04+00:00","page_url":"https://stenobird.com/podcast/montpelier-news-today-2-min-new-the-daily-news-now-7598987/glp-1-drugs-in-question-montpelier-news","show_page_url":"https://stenobird.com/podcast/montpelier-news-today-2-min-new-the-daily-news-now-7598987","url":"https://sources.thednn.ai/3e735e0ebefcbdde","audio_url":"https://api.fastcast.ai/audio/169cf6e2-7f95-4f9d-b609-2cdd26bd46dd.mp3","summary":"UVM Health Network is pulling coverage for GLP-1 weight-loss drugs, impacting hundreds of employees and saving nearly $19 million — but for users like Mike Popovitch, who lost 35 pounds in three weeks, it’s devastating news. As employers nationwide reassess ballooning prescription costs, the move reflects a growing trend to curb spending — even as research remains unclear on long-term savings. While diabetes and other medical uses stay covered, those relying on these drugs for weight loss now face steep out-of-pocket costs, forcing a painful choice between health and finances. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/3e735e0ebefcbdde","meta_description":"UVM Health Network is pulling coverage for GLP-1 weight-loss drugs, impacting hundreds of employees and saving nearly $19 million — but for users like Mik…","key_points":[],"chapters":[],"topics":[],"duration_seconds":109,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/montpelier-news-today-2-min-new-the-daily-news-now-7598987/episodes/glp-1-drugs-in-question-montpelier-news/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/montpelier-news-today-2-min-new-the-daily-news-now-7598987/glp-1-drugs-in-question-montpelier-news.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}